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TB-free 
World
• Provide person-centered diagnosis and treatment.
• Reach all populations at high risk for TB. 
• Strengthen and deliver prevention strategies in  
tandem with active case finding -interventions.
 » In Kenya, where rates of HIV/TB co-infection are 
high, scaling up access to both antiretroviral  
therapy and TB preventive therapy can help save 
an additional three million lives between now  
and 2045.
• Prioritize private-sector engagement. To defeat TB, 
we must recognize that the public sector cannot do 
it all.
 » In India, the country with the largest TB burden, 
optimizing private sector engagement could 
avert eight million deaths from TB between now 
and 2045.
• Provide universal access to drug susceptibility testing 
(DST) and ensure access to second-line DST for all 
persons with drug resistant TB (DR-TB). 
 » In Moldova, where more than 25 percent of all 
TB is drug-resistant, improving access to DST 
and second-line drugs would reduce DR TB  
mortality by 44% in the coming generation.
Building a Tuberculosis-free World
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FACT SHEET
The Lancet Commission set out to 
establish a roadmap for how high- 
burden countries could get on track 
to meet the goals established by the 
UN High Level Meeting (UNHLM) in 
September 2018. Commissioners met 
regularly over a period of 18 months  
to answer the question: “How should 
TB high-burden countries and their  
development partners target their future 
investments to ensure that ending TB  
is achieved?” The Report provides a 
comprehensive analysis and specific 
recommendations to address this  
question and, ultimately, remove the 
barriers to building a TB-free World.
The Report calls upon high-burden  
countries and the global community to 
pursue the following four strategies.
1. Implement 
and expand  
on proven, 
evidence-based 
strategies 
2. Invest to  
accelerate  
development  
of new tools
• Invest in and accelerate the pace of TB science,  
innovation, and development – transformative new 
tools are necessary to ensure we meet End TB targets 
by 2030.
 » Ensuring that 90% of persons with TB are found, 
diagnosed and treated, and ensuring 90% treat-
ment success can avert 2.2 million deaths/year 
from TB. To avert the remaining unavertable 
deaths (0.85 million/year) requires new tools.
• Invest in implementation, operational, and program-
matic research to rapidly translate research findings 
into TB control policies and programs to address 
public health needs. 
• Implement and scale up the use of existing  
biomedical and prevention tools.
• Deliver strong advocacy to science ministries and  
research-oriented pharmaceutical companies to  
ensure global commitment to TB research and  
development. 
 » This investment must be weighed against the 
cost of inaction: In India, even with optimal im-
plementation of all existing tools, unavoidable 
TB deaths will cost the economy at least US$32 
billion each year over the next 30 years.
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3. Make the 
case why TB is 
the “best buy” 
in global health
4. Create a new 
era of shared  
responsibility
• Improved domestic financing for TB is one of the 
biggest success stories in global health over the 
past two decades. 
 » Economic analysis commissioned for this 
report shows that the benefit of saving a life 
from TB is at least five times the cost of saving 
it – and may be much greater in many settings. 
• By 2017, 84% of funding for TB came from domestic 
sources. However, high-burden countries can do 
more to address their epidemic. Greater domestic 
resource mobilization can be achieved by increasing 
the distribution of public resources to health,  
pooling financing, and allocating tax revenues to 
health, especially in middle-income countries.
 » Countries like Bangladesh, Zambia, China,  
and Indonesia can increase their annual TB  
expenditures more than five-fold over the 
next five years, through increased revenue 
generation and allocation of greater  
budgetary resources to health.
• Expanding on efforts to enact new models of  
donor financing is vital; focusing on results,  
encouraging innovation and strengthening  
accountability.
• Establish greater accountability at all levels, from the 
level of Heads of State to the local TB clinics, to drive 
the change necessary to end the pandemic.
• Establish country-specific Report Cards to measure 
progress and determine where more resources are 
needed.
• Engage stakeholders from industry, civil society,  
multiple government ministries and the private sector.
• Ensure TB survivors and their advocates have a voice 
to raise inconvenient truths and demand action.
• Establish a Lancet Observatory to independently 
evaluate progress.
ROI:  
For every $ 
invested in 
intervention, 
up to $56 
are returned
Conclusion
Overall, the Commission states that the roadmap 
to Building a TB-free World is not a straight path, 
but rather a winding road that requires countries 
to be flexible as they respond to changing demo-
graphics, patient preferences and available data. 
While donor countries, funders and others share 
in the responsibility in breaking down the barriers 
to end TB, it is the country leaders who ultimately 
hold the keys to success. 
The Commission concludes that the prospect of 
a TB-free world is a realistic objective that can be 
achieved with the right commitment of leadership 
and resources. 
 
India
Lack of public sector  
engagement 
• Private sector prioritization by 
National TB Programs (NTPs)
• Private sector TB capability
• 28% mortality reduction
• 8 million lives saved
• $8bn cumulative NTP costs
Additional examples: Pakistan, 
Bangladesh, The Philippines
• ART scale up
• Optimized TB/HIV  
collaboration
• Universal TB preventive  
therapy scale up
• Universal DST
• Optimized access to second 
line drugs for all eligible 
patients
• 17% mortality reduction
• 3 million lives saved
• $1.8bn cumulative NTP costs
• 43% mortality reduction
• 15 thousand lives saved
Kenya
HIV/TB prevalence
Moldova
DR-TB prevalence
Additional Examples: South Africa, 
Nigeria, Tanzania
Additional Examples: Latvia,  
Central Asian Republics
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*Additional impact when interventions scaled up in concert with standard, optimal scale up  
of diagnostic, therapeutic and standard prevent interventions
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The original report “Building a tuberculosis-free world:  
The Lancet Commission on tuberculosis” was published in 
The Lancet on March 20, 2019 and is available online at  
www.thelancet.com/commissions/tuberculosis-free-world. 
